C
MET icon

CEDRUS’s MetLife MET Stock Holding History

CEDRUS’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$237K Sell
2,875
-1,737
-38% -$130K 0.09% 162
2024
Q2 		$324K Sell
4,612
-261
-5% -$18.6K 0.16% 115
2024
Q1 		$361K Sell
4,873
-1,203
-20% -$83.9K 0.2% 96
2023
Q4 		$402K Sell
6,076
-876
-13% -$54.8K 0.25% 83
2023
Q3 		$437K Buy
6,952
+1,159
+20% +$72.2K 0.31% 63
2023
Q2 		$327K Sell
5,793
-215
-4% -$11.9K 0.23% 102
2023
Q1 		$348K Sell
6,008
-805
-12% -$54.3K 0.24% 94
2022
Q4 		$493K Buy
6,813
+1,155
+20% +$82.7K 0.4% 53
2022
Q3 		$344K Buy
5,658
+222
+4% +$14.2K 0.32% 64
2022
Q2 		$341K Buy
5,436
+789
+17% +$52.2K 0.33% 61
2022
Q1 		$327K Buy
4,647
+145
+3% +$9.8K 0.29% 88
2021
Q4 		$281K Buy
+4,502
New +$283K 0.27% 106

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

CEDRUS's MET Position: Q3 2024 in Review

CEDRUS reduced its MetLife (MET) stake by 38% in Q3 2024, selling an estimated $130K and leaving 2,875 shares worth $237K. The position accounts for 0.09% of the portfolio, ranked #162.

CEDRUS first reported a position in MET in Q4 2021 and has held it in 12 quarters since. The position peaked at $493K in Q4 2022. 1,317 funds tracked by Wall St. Rank hold MET as of Q3 2024.

  • CEDRUS held 2,875 shares of MetLife worth $237K as of Q3 2024.
  • CEDRUS sold 1,737 MetLife shares in Q3 2024, an estimated $130K.
  • MetLife made up 0.09% of CEDRUS's portfolio in Q3 2024, its #162 holding.
  • CEDRUS first reported a position in MetLife in Q4 2021 and has held it in 12 quarters since.
  • CEDRUS's MetLife position peaked at $493K in Q4 2022.
  • 1,317 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.